148 related articles for article (PubMed ID: 2162834)
1. Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action.
Knaus HG; Scheffauer F; Romanin C; Schindler HG; Glossmann H
J Biol Chem; 1990 Jul; 265(19):11156-66. PubMed ID: 2162834
[TBL] [Abstract][Full Text] [Related]
2. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
Staudinger R; Knaus HG; Glossmann H
J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
[TBL] [Abstract][Full Text] [Related]
3. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Murphy BJ; Tuana BS
Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
[TBL] [Abstract][Full Text] [Related]
4. Molecular approach to the calcium channel.
Glossmann H; Ferry DR; Goll A; Linn T
Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
[TBL] [Abstract][Full Text] [Related]
5. Purified calcium channels have three allosterically coupled drug receptors.
Striessnig J; Goll A; Moosburger K; Glossmann H
FEBS Lett; 1986 Mar; 197(1-2):204-10. PubMed ID: 2419161
[TBL] [Abstract][Full Text] [Related]
6. In vivo labeling of L-type Ca2+ channels by fluorescent dihydropyridines: evidence for a functional, extracellular heparin-binding site.
Knaus HG; Moshammer T; Friedrich K; Kang HC; Haugland RP; Glossman H
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3586-90. PubMed ID: 1314393
[TBL] [Abstract][Full Text] [Related]
7. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
Hagiwara M; Adachi-Akahane S; Nagao T
J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
[TBL] [Abstract][Full Text] [Related]
8. Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.
Galizzi JP; Borsotto M; Barhanin J; Fosset M; Lazdunski M
J Biol Chem; 1986 Jan; 261(3):1393-7. PubMed ID: 3003067
[TBL] [Abstract][Full Text] [Related]
9. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
[TBL] [Abstract][Full Text] [Related]
10. A novel high affinity class of Ca2+ channel blockers.
Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
[TBL] [Abstract][Full Text] [Related]
11. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
Kanngiesser U; Pongs O
Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
[TBL] [Abstract][Full Text] [Related]
12. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166.
Striessnig J; Meusburger E; Grabner M; Knaus HG; Glossmann H; Kaiser J; Schölkens B; Becker R; Linz W; Henning R
Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):331-40. PubMed ID: 2839780
[TBL] [Abstract][Full Text] [Related]
14. A light stabilizer (Tinuvin 770) that elutes from polypropylene plastic tubes is a potent L-type Ca(2+)-channel blocker.
Glossmann H; Hering S; Savchenko A; Berger W; Friedrich K; Garcia ML; Goetz MA; Liesch JM; Zink DL; Kaczorowski GJ
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9523-7. PubMed ID: 8415734
[TBL] [Abstract][Full Text] [Related]
15. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
Reynolds IJ; Snowman AM; Snyder SH
J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
[TBL] [Abstract][Full Text] [Related]
16. Effects of four diltiazem stereoisomers on binding of d-cis-[3H]diltiazem and (+)-[3H]PN200-110 to rabbit T-tubule calcium channels.
Ikeda S; Oka J; Nagao T
Eur J Pharmacol; 1991 Nov; 208(3):199-205. PubMed ID: 1663043
[TBL] [Abstract][Full Text] [Related]
17. Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2+ channel.
Shimasue K; Urushidani T; Hagiwara M; Nagao T
Eur J Pharmacol; 1996 Feb; 296(3):347-50. PubMed ID: 8904088
[TBL] [Abstract][Full Text] [Related]
18. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.
Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307
[TBL] [Abstract][Full Text] [Related]
19. Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.
Striessnig J; Murphy BJ; Catterall WA
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10769-73. PubMed ID: 1660150
[TBL] [Abstract][Full Text] [Related]
20. Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine.
Nakayama H; Taki M; Striessnig J; Glossmann H; Catterall WA; Kanaoka Y
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9203-7. PubMed ID: 1656465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
